{"id":423681,"date":"2019-08-28T09:54:01","date_gmt":"2019-08-28T09:54:01","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=423681"},"modified":"2019-08-28T09:54:01","modified_gmt":"2019-08-28T09:54:01","slug":"neuroprosthetics-market-size-will-grow-at-a-cagr-of-124-owing-to-rising-prevalence-of-neurological-disorders-overactive-bladder-syndrome-and-technological-advancement-till-2023","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/neuroprosthetics-market-size-will-grow-at-a-cagr-of-124-owing-to-rising-prevalence-of-neurological-disorders-overactive-bladder-syndrome-and-technological-advancement-till-2023_423681.html","title":{"rendered":"Neuroprosthetics Market Size Will Grow at a CAGR oF 12.4% Owing To Rising Prevalence of Neurological Disorders, Overactive Bladder Syndrome and Technological Advancement Till 2023"},"content":{"rendered":"
\"Neuroprosthetics<\/a><\/div>\n
Neuroprosthetics Market Overview and Analysis By Type, Applications, Top Key Companies Profile, End Users, Regional Outlook and Segmentation, Forecast to 2023<\/p>\n<\/div>\n

Neuroprosthetics Market<\/strong> To Represent 12.4% CAGR By 2023. The Neuroprosthetics domain refers to a blend of neuroscience and biomedical engineering. Neuroprosthetics refers to a series of equipment which is used as a substitute for sensory motor and cognitive abilities of a human. Primarily, neuroprosthetics is used when injuries or diseases cause neurological damage in a human.<\/p>\n

Global Neuroprosthetics Market is likely to reach a revenue valuation of USD 10.48 billion by the end of the forecast period. Such market growth can be attributed to various factors including increasing prevalence in neural diseases, overactive bladder syndrome, and various chronic disorders such as epilepsy and parkinson’s disease. Further, advanced technologies are providing tools that don’t need implanting and are minimally invasive, hence, driving accelerated growth to the global neuroprosthetics market during the forecast period.<\/p>\n

Request Free Sample Report at:<\/strong> https:\/\/www.marketresearchfuture.com\/sample_request\/6782<\/strong><\/a><\/strong><\/p>\n

Neuroprosthetics<\/strong> Market Key Players<\/strong><\/p>\n

The report on Neuroprosthetics Market prominent players include<\/strong><\/p>\n

• Cochlear (Australia)
• Abbott (US)
• Neuropace (US)
• Medtronic (US)
• Boston Scientific (US)
• Sonova (UK)
• Livanova (UK)
• Med-El (UK)
• Retina Implant (US)
• Nevro (California)
• Second Sight (US)<\/strong><\/p>\n

Neuroprosthetics<\/strong> Market Segmentation<\/strong><\/p>\n

Global Neuroprosthetics Market has been segmented on the basis of<\/p>\n

• type
• technology
• applications
• end users
• region<\/p>\n

On the basis of type, the global neuroprosthetics market is segmented into output neuroprosthetics and input neuroprosthetics. The output neuroprosthetics segment is for the sub- segmented into cognitive prosthetics and motor prosthetics. On the other hand, the input prosthetics segment is further sub-segmented into cochlear implant and visual prosthetics.<\/p>\n

On the basis of techniques, the global neuroprosthetics market segment into deep brain stimulation, vagus nerve stimulation, spinal cord stimulation, and sacral nerve stimulation. Based on end users, the global neuroprosthetics market is segmented into diagnostic centers, hospitals and clinics, and research centers.<\/p>\n

Based on application, the global neuroprosthetics market segment into physiological disorders, motor neuron disorders, and cognitive disorders. The motor neuron disorder segment is sub-segmented into parkinson’s disease and epilepsy disorder. The physiological disorders segmentation further includes sub-segments of ophthalmic disorders, auditory processing disorders, neurology disorders, and cardiovascular disorders. The cognitive disorders segment is further sub-segmented into alzheimer’s disease paralysis and severe depression.<\/p>\n

Detailed Regional Analysis<\/strong><\/p>\n

The Global Neuroprosthetics Market is regionally segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa.<\/p>\n

America<\/strong>
• North America
• US
• Canada
• South America<\/p>\n

Europe<\/strong>
• Western Europe
• Germany
• UK
• France
• Italy
• Spain
• Rest Of Western Europe
• Eastern Europe<\/p>\n

Asia<\/strong>
• Japan
• China
• India
• Australia
• Republic Of Korea
• Rest Of Asia Pacific<\/p>\n

Middle East & Africa<\/strong>
• United Arab Emirates
• Saudi Arabia
• Oman
• Kuwait
• Qatar
• Rest Of Middle East & Africa<\/p>\n

Browse Full Report Details at:<\/strong> https:\/\/www.marketresearchfuture.com\/reports\/neuroprosthetics-market-6782<\/a><\/strong><\/p>\n

About Market Research Future:<\/strong><\/p>\n

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Market Research Future<\/a>
Contact Person:<\/strong> Abhishek Sawant
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +1 646 845 9312
Address:<\/strong>Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City:<\/strong> Pune
State:<\/strong> Maharashtra
Country:<\/strong> India
Website:<\/strong> www.marketresearchfuture.com\/reports\/neuroprosthetics-market-6782<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Neuroprosthetics Market Overview and Analysis By Type, Applications, Top Key Companies Profile, End Users, Regional Outlook and Segmentation, Forecast to 2023 Neuroprosthetics Market To Represent 12.4% CAGR By 2023. The Neuroprosthetics domain refers to a blend of neuroscience and biomedical engineering. … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,417,412,406],"tags":[],"class_list":["post-423681","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Marketing-Sales","category-News-Current-Affairs","category-Pharmaceuticals-Biotech"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/423681","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=423681"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/423681\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=423681"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=423681"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=423681"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}